U.S. Tendon Repair Market Size to Hit Around USD 1,627.65 Million by 2034
The U.S. tendon repair market size was exhibited at USD 746.97 million in 2024 and is projected to hit around USD 1,627.65 million by 2034, growing at a CAGR of 8.1% during the forecast period 2025 to 2034.
U.S. Tendon Repair Market Key Takeaways:
?????????????? ?????? ???????? ???????????? ????????????: https://www.novaoneadvisor.com/report/sample/8271
This can be attributed to the rising geriatric population, increasing demand for minimally invasive procedures, and the growing number of tendon-related injuries in sports & other events. In addition, the wear and tear of soft tissues in the elderly or geriatric population, resulting from weakened connective tissues, is anticipated to drive the market growth. Moreover, the increasing number of accidents, particularly road accidents, is further expected to propel the demand for soft tissue repairs, including tendon repair.
Rising adoption of orthopedic robotic platforms in hospitals further accelerated market expansion. For instance, in March 2022, SRV Hospital, with Lokmanya Hospital, Launched a new center for excellence in robotic orthopedics. The newly launched center is equipped with Smith+Nephew’s handheld robotic device for knee surgeries. In addition, several key players such as Smith & Nephew, Stryker, & DePuy Synthes are shifting focus and developing robotic surgery. For instance, in October 2022, THINK Surgical, a leader in orthopedic surgical robots, announced that KDB investment Global Healthcare Korea invested USD 100 million in THINK Surgical to allow faster launch of novel products.
Moreover, shifting landscape of demographics in the U.S., marked by a notable increase in overall life expectancy, is reshaping the healthcare landscape. One significant consequence is the steady growth of the geriatric population. As per the U.S. Census Bureau's 2022 data, approximately 56 million individuals fall within the geriatric demographic. Projections indicate that by 2030, this figure is expected to surpass 73.1 million. This demographic shift is poised to have profound implications on healthcare, particularly in musculoskeletal disorders.
U.S. Tendon Repair Market By Application Insights
Rotator cuff repair segment held the largest revenue share of 37.6% in U.S. tendon repair in 2024, owing to a high incidence of rotator cuff injuries because of various physical activities. Sports players and athletes commonly suffer such types of injuries. For instance, according to statistics provided by Great Basin Orthopedics, around 200,000 people in the U.S. require surgery to repair rotator cuffs yearly. This signifies the growth potential of the market. Furthermore, introducing newer cuff rotator procedures is expected to facilitate surgery rates, thereby reducing invasion and surgery time. For instance, in February 2022, UAB Orthopedics introduced a newer approach to rotator cuff repair by launching the subacromial balloon spacer procedure. With this procedure, patients can safely rehabilitate their shoulders with the help of physical therapy.
Achilles tendinosis repair segment is expected to witness the fastest growth rate over the forecast period. The Achilles tendon has become a major concern for athletes and other active individuals with chronic conditions. Thus, managing and repairing this condition is important to avoid complications like tendon rupture and chronic pain. Healthcare organizations, hospitals, and manufacturers in the tendon repair market are taking collaborative measures to tackle the situation. For instance, in October 2022, physiatrists in the Department of Rehabilitation Medicine and surgeons at HHS at Weill Cornell Medicine collaborated to manage Achilles tendinopathies, offering proper diagnosis and surgical & nonsurgical treatment options for tackling this condition. In addition, in March 2022, Acumed LLC, using Acu-Sinch Knotless technology, launched Ankle Syndesmosis Repair System to stabilize injuries or laxity in the tibiofibular syndesmosis.
U.S. Tendon Repair Market By Product Type Insights
Suture anchor devices segment dominated the market regarding revenue share in the U.S. tendon repair market in 2024. The segment's dominance is due to the increasing use of anchor devices in tendon repair surgeries. They are a primary choice in arthroscopy procedures due to their higher strength. Suture anchors can be knotless or knotted based on the type of injury used. Moreover, key players are focusing on developing sutures to provide better surgical procedures to the target population. For instance, in September 2022, Mesh Suture, Inc. received FDA approval for a non-absorbable polypropylene mesh suture, which can be used for soft tissues, including tendons, ligaments, fascia, and muscles.
Implants segment is expected to show the fastest growth rate over the forecast period. The growth of the tendon implants market is due to increased sports injuries and a rise in the geriatric population. Implants are routinely preferred over allografts and autografts because use of implants is usually associated with faster recovery time, lesser compatibility issues, and reduced surgical procedure time. Moreover, increasing demand for tendon repair techniques is further propelling the need to introduce and develop newer products by key manufacturing with high mechanical capabilities. In January 2024, Arthrex, Inc. received FDA approval for an ACL TightRope implant used in the surgical treatment of orthopedic injuries for pediatric use. Furthermore, the increasing research on tendon repair techniques and solutions has made them more accessible to patients.
Some of the prominent players in the U.S. tendon repair market include:
U.S. Tendon Repair Market Recent Developments
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. tendon repair market
By Application
By Product Type
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/8271
Access our Premium Real Time Data Intelligence Tool, Visit: https://www.statifacts.com/
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344
Nova One Advisor Group Offer Other Reports:
Automated and Closed Cell Therapy Processing System Market https://www.biospace.com/press-releases/automated-and-closed-cell-therapy-processing-systems-market-size-to-hit-usd-11-36-billion-by-203
Allogeneic Cell Therapy Market - https://www.biospace.com/press-releases/allogeneic-cell-therapy-market-size-to-hit-usd-4-677-38-million-by-203
Bioinformatics Services Market - https://www.biospace.com/press-releases/bioinformatics-services-market-size-to-hit-usd-14-10-billion-by-203
U.S. Radiation Oncology Market - https://www.biospace.com/press-releases/u-s-radiation-oncology-market-size-to-hit-usd-14-56-billion-by-2033
Hemoglobinopathies Market - https://www.biospace.com/press-releases/hemoglobinopathies-market-size-to-hit-usd-34-76-billion-by-203
U.S. gene therapy market - https://www.biospace.com/press-releases/u-s-gene-therapy-market-size-to-hit-usd-18-50-billion-by-2033
Asthma and COPD Drugs Market - https://www.biospace.com/press-releases/asthma-and-copd-drugs-market-size-to-hit-usd-59562-82-million-by-2034
U.S. Biopharmaceuticals Contract Manufacturing Market - https://www.biospace.com/press-releases/u-s-biopharmaceuticals-contract-manufacturing-market-size-to-hit-usd-7-83-billion-by-2033
North America Molecular Diagnostics Market - https://www.biospace.com/press-releases/north-america-molecular-diagnostics-market-size-to-hit-usd-8-91-billion-by-2034
Separation Systems for Commercial Biotechnology Market - https://www.biospace.com/press-releases/separation-systems-for-commercial-biotechnology-market-size-to-hit-usd-46-78-billion-by-2033
U.S. Biosensors Market - https://www.biospace.com/press-releases/u-s-biosensors-market-size-to-surpass-usd-19-63-billion-by-2033
U.S. Biotechnology Market - https://www.biospace.com/press-releases/u-s-biotechnology-market-size-to-hit-usd-1-794-11-billion-by-203
U.S. Intravenous Immunoglobulin Market - https://www.biospace.com/press-releases/u-s-intravenous-immunoglobulin-market-size-to-hit-usd-14-42-billion-by-2033
U.S. Tissue Engineering Market - https://www.biospace.com/press-releases/u-s-tissue-engineering-market-size-to-hit-usd-69-00-billion-by-203
?